US$ 23.70
glp-1 receptor agonist type 1 diabetes trial liraglutide Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-like peptide 1 receptor agonists
Description
Trulicity Lillys Patient-Friendly Ready-to-Use once weekly GLP-1 agonist Trulicity approved in the US FDA approves Trulicity for type 2 diabetess, 1st once-weekly GLP-1 agonist in the US that comes ready-to-use launch for later this year
Jung HK, Choung RS, Locke GR, 3rd, et al

10.1093/brain/aws059 [DOI] [PubMed] [Google Scholar] Zhang R

Early and late complications of bariatric operation

271: R848R856 [DOI] [PubMed] [Google Scholar] 153.Turton MD, OShea D, Gunn I, et al
